Cohance Lifesciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2025 ,inter alia, to consider and approve the Unaudited Financial Results (Standalone and Consolidated) of the Company, for the quarter ending June 30, 2025